XRTX logo

XORTX Therapeutics (XRTX) Shareholders Equity

Annual Shareholders Equity

$4.64 M
-$2.35 M-33.66%

December 1, 2023


Summary


Performance

XRTX Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXRTXbalance sheetmetrics:

Quarterly Shareholders Equity

$2.13 M
-$571.10 K-21.12%

September 1, 2024


Summary


Performance

XRTX Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXRTXbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

XRTX Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-33.7%-54.0%
3 y3 years+371.2%-76.5%
5 y5 years+1866.1%-76.5%

XRTX Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-64.8%at low-83.8%at low
5 y5-year-64.8%+2963.7%-83.8%+164.2%
alltimeall time-64.8%+991.7%-83.8%+164.2%

XORTX Therapeutics Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
$2.13 M(-21.1%)
Jun 2024
-
$2.70 M(+8.6%)
Mar 2024
-
$2.49 M(-46.3%)
Dec 2023
$4.64 M(-33.7%)
$4.64 M(-23.7%)
Sep 2023
-
$6.09 M(-17.7%)
Jun 2023
-
$7.40 M(-18.3%)
Mar 2023
-
$9.06 M(+29.5%)
Dec 2022
$7.00 M(-47.0%)
$7.00 M(-10.6%)
Sep 2022
-
$7.83 M(-17.6%)
Jun 2022
-
$9.50 M(-11.5%)
Mar 2022
-
$10.73 M(-18.7%)
Dec 2021
$13.20 M(+1240.1%)
-
Dec 2021
-
$13.20 M(-497.3%)
Sep 2021
-
-$3.32 M(-224.1%)
Jun 2021
-
$2.68 M(-2.6%)
Mar 2021
-
$2.75 M(+179.1%)
Dec 2020
$985.20 K(-707.8%)
$985.20 K(-21.0%)
Sep 2020
-
$1.25 M(-15.0%)
Jun 2020
-
$1.47 M(-4.9%)
Mar 2020
-
$1.54 M(-1052.1%)
Dec 2019
-$162.10 K
-$162.10 K(+112.7%)
DateAnnualQuarterly
Sep 2019
-
-$76.20 K(-585.4%)
Jun 2019
-
$15.70 K(-87.1%)
Mar 2019
-
$121.60 K(-48.5%)
Dec 2018
$236.10 K(-145.4%)
$236.10 K(-33.7%)
Sep 2018
-
$356.30 K(-37.4%)
Jun 2018
-
$568.90 K(-26.4%)
Mar 2018
-
$772.90 K(-248.5%)
Dec 2017
-$520.60 K(-487.4%)
-$520.60 K(-1687.2%)
Nov 2017
-
$32.80 K(-109.5%)
Sep 2017
-
-$346.70 K(-806.1%)
Aug 2017
-
$49.10 K(-49.0%)
May 2017
-
$96.30 K(-28.3%)
Feb 2017
$134.40 K(-157.0%)
$134.40 K(-59.7%)
Dec 2016
-$235.90 K(-219.6%)
-
Nov 2016
-
$333.10 K(+154.9%)
Aug 2016
-
$130.70 K(-23.6%)
May 2016
-
$171.10 K(-13.3%)
Feb 2016
$197.30 K(+105.7%)
$197.30 K(-14.3%)
Nov 2015
-
$230.20 K(+416.1%)
Aug 2015
-
$44.60 K(-47.5%)
May 2015
-
$85.00 K(-11.4%)
Feb 2015
$95.90 K
$95.90 K

FAQ

  • What is XORTX Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for XORTX Therapeutics?
  • What is XORTX Therapeutics annual shareholders equity year-on-year change?
  • What is XORTX Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for XORTX Therapeutics?
  • What is XORTX Therapeutics quarterly shareholders equity year-on-year change?

What is XORTX Therapeutics annual stockholders equity?

The current annual shareholders equity of XRTX is $4.64 M

What is the all time high annual shareholders equity for XORTX Therapeutics?

XORTX Therapeutics all-time high annual stockholders equity is $13.20 M

What is XORTX Therapeutics annual shareholders equity year-on-year change?

Over the past year, XRTX annual stockholders equity has changed by -$2.35 M (-33.66%)

What is XORTX Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of XRTX is $2.13 M

What is the all time high quarterly shareholders equity for XORTX Therapeutics?

XORTX Therapeutics all-time high quarterly stockholders equity is $13.20 M

What is XORTX Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, XRTX quarterly stockholders equity has changed by -$2.51 M (-54.04%)